Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib
Nina Prokoph, Jamie D. Matthews, Ricky M. Trigg, Ivonne A. Montes-Mojarro, G. A.Amos Burke, Falko Fend, Olaf Merkel, Lukas Kenner, Birgit Geoerger, Robert Johnston, Matthew J. Murray, Charlotte Riguad, Laurence Brugières, Suzanne D. Turner*
Research output: Contribution to journal › Article › peer-review
23Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib'. Together they form a unique fingerprint.